Retrospective study of 20 RA pts w/ resolved hepatitis B (HBcAb+; HBsAg neg). 16/20 were Rx w/ tocilizumab & 8/20 w/ tofacitinib (nearly all HBsAb+). 25% recv antiviral Rx w/in 2 yrs of TCZ or Tofa; 6 had mild LFT elevations & No one had HBV reactivation https://t.co/EeFXo7mLhQ